All Research on Pharmaceuticals and Healthcare in Denmark

Insight

Premium Report
Premium Report

Pharmaceuticals in Denmark - Industry and Country Analysis

Pharmaceuticals in Denmark - Industry and Country Analysis provides five forces Industry analysis, along with PESTLE country analysis of Denmark. This report concludes with profiles of the leading companies in the Danish pharmaceuticals market.

Published By Datamonitor
$395
Buy

Profiles

Company Profile
Company Profile

Genmab A/S

Genmab (or 'the company') is a biotechnology company engaged in the discovery and development of human antibodies for the treatment of life-threatening and debilitating diseases. The company's therapeutic emphasis is in the areas of cancer, infectious diseases, rheumatoid arthritis and other inflammatory conditions. It is headquartered in Copenhagen, Denmark and employed 157 people as of December 31, 2013.

Published By MarketLine
$175
Buy
Company Profile
Company Profile

ALK-Abello AS

ALK-Abello (or 'the group') is a Denmark-based pharmaceutical group engaged in the development and marketing of allergy treatment products. The group operates in Europe, North America and other parts of the world. It is headquartered in Horsholm, Denmark, and employed 1,763 people as on December 31, 2013.

Published By MarketLine
$175
Buy
Company Profile
Company Profile

Novo Nordisk A/S

Novo Nordisk (or 'the company') is a leading global provider of diabetes products. The company also has a leadership position in hemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk primarily operates in Europe, North America and Japan. It is headquartered in Bagsvaerd, Denmark, and employed 38,436 people as of December 31, 2013.

Published By MarketLine
$175
Buy

View all Profiles >>

No help is available.